Call or text us at 613-800-0188

Screening

Screening Frequency

Ask Masi recommends screening for depression* and anxiety at the following points in time:

  • the first prenatal visit
  • 26-28 weeks of pregnancy
  • 6 weeks postpartum


If your patient is high-risk, we recommend additional screening at 2 weeks postpartum.

*If a patient screens positive for depression, we recommend screening for bipolar disorder with the MDQ as well.


Why screen for bipolar disorder?

- It is important to screen for bipolar disorder because 1 in 5 patients who screen positive for perinatal depression may have bipolar disorder.

- Treating with an unopposed antidepressant can induce mania, mixed states, and rapid cycling, all of which carry significant risks.

- Bipolar disorder is associated with increased risk of postpartum psychosis and postpartum psychosis is associated with suicide and infanticide.


Screening Tools

Depression

Edinburgh Postnatal Depression Scale (EPDS) (Form-fillable; Printable; English)

The EPDS has been translated into many other languages, including French, and these versions can be found here.


Anxiety

GAD-7 Patient Screening Tool (Form fillable; Printable; English)

GAD-7 (French)

Depression and Anxiety Combined Screening

Combined EPDS and GAD-7 Screening Tool (Form fillable; Printable; English)

Bipolar Disorder

MDQ

PTSD

PCL-5

Suicide Risk Assessment Tool

Columbia-Suicide Severity Rating Scale (C-SSRS) - PDF

About the C-SSRS

ANRQ (Psychosocial) Risk Questionnaire

ANRQ - Client

ANRQ with Family Violence & Drug/Alcohol Questions - Client

ANRQ Postnatal Version with FV & D+A Questions - Client

ANRQ Clinician Instructions

ANRQ Scoring Guide